Literature DB >> 2828748

Ontogenesis of angiotensin-I converting enzyme in human kidney.

F Mounier1, N Hinglais, M Sich, F Gros, M Lacoste, Y Deris, F Alhenc-Gelas, M C Gubler.   

Abstract

The kidney distribution of angiotensin-I converting enzyme (ACE) was studied in 14 fetuses (11 to 30 weeks old) and 7 children (2 days to 13 years old) by immunohistochemistry using specific antibodies to human kidney ACE. Immunohistochemical techniques included indirect immunofluorescence on cryostat sections of frozen tissue, immunoperoxidase and immunofluorescence of fixed tissue embedded in Paraplast, and immunoelectron microscopy. The ACE distribution in the fetal kidneys was independent of the age of the fetus. ACE was detected in two locations: 1) on the basolateral membranes and primary apical microvilli of epithelial cells from early differentiating proximal tubules; the labeling was intense in brush borders of fully developed proximal tubules; and 2) on glomerular endothelial cells; cells were lined by reaction product as soon as capillaries invaded the inferior cleft of the S-shaped body. Tubular ACE distribution was identical in the postnatal kidneys. The staining of the glomerular endothelium was extremely inconstant. The presence of ACE in proximal tubular cells and glomerular endothelial cells at the beginning of nephron differentiation may indicate that it is involved in the development of nephron function and renal hemodynamic.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2828748     DOI: 10.1038/ki.1987.261

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

Review 1.  ACE and ACE2 in kidney disease.

Authors:  Sonoo Mizuiri; Yasushi Ohashi
Journal:  World J Nephrol       Date:  2015-02-06

Review 2.  Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

3.  The urinary activity of angiotensin-converting enzyme in preterm, full-term newborns, and children.

Authors:  Graziela Lopes Del Ben; Beata Marie Redublo Quinto; Dulce Elena Casarini; Luiz Carlos Bueno Ferreira; Sérgio Sousa Ayres; João Tomás de Abreu Carvalhaes
Journal:  Pediatr Nephrol       Date:  2006-06-30       Impact factor: 3.714

4.  Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation.

Authors:  F Niimura; P A Labosky; J Kakuchi; S Okubo; H Yoshida; T Oikawa; T Ichiki; A J Naftilan; A Fogo; T Inagami
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

Review 5.  Nephron number, hypertension, and CKD: physiological and genetic insight from humans and animal models.

Authors:  Xuexiang Wang; Michael R Garrett
Journal:  Physiol Genomics       Date:  2017-01-27       Impact factor: 3.107

Review 6.  Molecular biology of components of the renin-angiotensin system during development.

Authors:  R A Gomez
Journal:  Pediatr Nephrol       Date:  1990-07       Impact factor: 3.714

7.  Role of cortisol in the ontogenic control of pulmonary and renal angiotensin-converting enzyme in fetal sheep near term.

Authors:  A J Forhead; C E Gillespie; A L Fowden
Journal:  J Physiol       Date:  2000-07-15       Impact factor: 5.182

8.  (Pro)renin and (pro)renin receptor expression during kidney development in neonates.

Authors:  Tomomasa Terada; Maki Urushihara; Takahiko Saijo; Ryuji Nakagawa; Shoji Kagami
Journal:  Eur J Pediatr       Date:  2016-12-19       Impact factor: 3.183

Review 9.  Renin-angiotensin system in ureteric bud branching morphogenesis: implications for kidney disease.

Authors:  Ihor V Yosypiv
Journal:  Pediatr Nephrol       Date:  2013-09-07       Impact factor: 3.714

10.  Angiotensin converting enzyme in renal ontogeny: hypothesis for multiple roles.

Authors:  F F Jung; B Bouyounes; R Barrio; S S Tang; D Diamant; J R Ingelfinger
Journal:  Pediatr Nephrol       Date:  1993-12       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.